Utilizing Long-read Sequencing to Investigate the EGFR Landscape of EGFR Positive Lung Cancer Patients
Part of paid clinical trials in Baton Rouge, Louisiana.
- Sponsor
- Our Lady of the Lake Hospital
- Study ID
- NCT06659458
- Status
- Recruiting
Conditions
- EGFR Exon 19 Deletion Mutation
- Lung Cancer - Non Small Cell
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 100 Years
- Healthy Volunteers
- Accepted
Interventions
- blood draw — OTHERA 10ml Blood sample will be taken and used to sequence the EGFR gene and surrounding DNA.
- Gene sequencing — OTHERSubjects will have their DNA sequenced within and around the EGFR gene.
Study Details
EGFR gene mutations are some of the most commonly occurring mutations in non-small cell lung cancer. Investigators have developed a DNA instability model that estimates a risk score to assess the likelihood of an individual acquiring a cancer-linked mutation. The aim of this study is to collect blood from both those diagnosed with EGFR positive lung cancer and healthy individuals, evaluate their gene sequence surrounding the EGFR landscape and use the cancer positive and healthy sequences to validate the risk assessment model, which may one day be used to provide insight on susceptibility of getting EGFR positive lung cancer or potentially other cancer types.
Key Dates
- Start date
- Jan 1, 2025
- Status verified
- Oct 2024
- Primary completion
- Dec 31, 2025
- Completion
- Dec 31, 2025
Study Design
- Enrollment
- 20 participants (estimated)
Arms
- Arm: EGFR Positive Lung CancerSubjects diagnosed with EGFR positive lung cancer
- Arm: Healthy SubjectsSubjects who do not have a cancer diagnosis
Primary Outcome Measure
Differences in DNA sequence of EGFR gene [ Time Frame: From enrollment to end of data analysis at 6 months ]
Central Contacts
- Cynthia Knox, MBA225-765-3344
- Christine LeBoeuf, DNP225-763-5956
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Our Lady of the Lake Regional Medical Center | Baton Rouge | Louisiana | 70808 | - |
Find similar trials in Baton Rouge, LA
Related Studies
- The Impact of Exercise on the Tumor Microenvironment in Patients With Lung CancerRecruiting · University of Arizona · Tucson, Arizona
- Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLCPHASE2 · Not Yet Recruiting · Massachusetts General Hospital · Boston, Massachusetts